Guo Dongmin, Zhang David, Li Naimin, Zhang Lei, Yang Jianhua
IEEE Trans Biomed Eng. 2010 Nov;57(11). doi: 10.1109/TBME.2010.2055864. Epub 2010 Jul 26.
Certain gases in the breath are known to be indicators of the presence of diseases and clinical conditions. These gases have been identified as biomarkers using equipments such as gas chromatography (GC) and electronic nose (e-nose). GC is very accurate but is expensive, time consuming, and non-portable. E-nose has the advantages of low-cost and easy operation, but is not particular for analyzing breath odor and hence has a limited application in diseases diagnosis. This article proposes a novel system that is special for breath analysis. We selected chemical sensors that are sensitive to the biomarkers and compositions in human breath, developed the system, and introduced the odor signal preprocessing and classification method. To evaluate the system performance, we captured breath samples from healthy persons and patients known to be afflicted with diabetes, renal disease, and airway inflammation repectively and conducted experiments on medical treatment evaluation and disease identification. The results show that the system is not only able to distinguish between breath samples from subjects suffering from various diseases or conditions (diabetes, renal disease, and airway inflammation) and breath samples from healthy subjects, but in the case of renal failure is also helpful in evaluating the efficacy of hemodialysis (treatment for renal failure).
已知呼出气体中的某些气体是疾病和临床状况存在的指标。这些气体已通过气相色谱(GC)和电子鼻(e-nose)等设备被鉴定为生物标志物。气相色谱非常准确,但价格昂贵、耗时且不可携带。电子鼻具有低成本和操作简便的优点,但对分析呼吸气味不具有特异性,因此在疾病诊断中的应用有限。本文提出了一种专门用于呼吸分析的新型系统。我们选择了对人体呼出气体中的生物标志物和成分敏感的化学传感器,开发了该系统,并介绍了气味信号预处理和分类方法。为了评估系统性能,我们分别从健康人以及已知患有糖尿病、肾病和气道炎症的患者身上采集了呼吸样本,并进行了医疗治疗评估和疾病识别实验。结果表明,该系统不仅能够区分患有各种疾病或状况(糖尿病、肾病和气道炎症)的受试者的呼吸样本与健康受试者的呼吸样本,而且在肾衰竭的情况下,还有助于评估血液透析(肾衰竭治疗方法)的疗效。